MedTrace Logo

Telemedicine With Metabolic Syndrome

NCT05117580 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2021-11-11

No results posted yet for this study

Summary

Investigation of the effect of a 3-month telemedicine-led lifestyle intervention on cardiovascular risk factors, functional indicators, in patients with metabolic syndrome.

Conditions

  • Metabolic Syndrome
  • Life Style

Interventions

DEVICE

telemedicine lifestyle guidance

Telemedicine lifestyle advices are given during 3 months, based on telemonitoring system data.

Sponsors & Collaborators

  • Szeged University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05117580 on ClinicalTrials.gov